Pfizer's 8-K reports that its board elected Dr. Scott Gottlieb as a director on June 27, 2019, and placed him on the Regulatory and Compliance and Science and Technology committees.
On June 27, 2019, the Board of Directors of Pfizer Inc. (the “Company”) elected Dr. Scott Gottlieb to serve as a member of the Company’s Board of Directors, effective immediately.
Item 5.02
Pfizer's 8-K reports that its board elected Dr. Scott Gottlieb as a director on June 27, 2019, and placed him on the Regulatory and Compliance and Science and Technology committees. Company filing, no funder. Pfizer is the company; Gottlieb had left FDA in April 2019, about two months before. No comparator. EDGAR serves HTM only, so pdf_url is empty. Pfizer's press release of the same date is Exhibit 99 to this filing. Study type: regulatory record.
